Bulletin
Investor Alert

press release

Oct. 22, 2021, 7:00 a.m. EDT

HCA Healthcare Reports Third Quarter 2021 Results; Revises 2021 Guidance

NASHVILLE, Tenn., (BUSINESS WIRE) -- HCA Healthcare, Inc. /zigman2/quotes/205934574/composite HCA +1.02% today announced financial and operating results for the third quarter ended September 30, 2021.

Key third quarter metrics (all percentage changes compare 3Q 2021 to 3Q 2020 unless otherwise noted):

  • Revenues totaled $15.276 billion

  • Net income attributable to HCA Healthcare, Inc. totaled $2.269 billion, or $7.00 per diluted share

  • Adjusted EBITDA totaled $3.224 billion

  • Cash flows from operating activities totaled $2.277 billion

  • Same facility admissions and same facility equivalent admissions increased 6.8 percent and 9.3 percent, respectively

“During the third quarter we experienced the most intense surge yet of the pandemic, and our colleagues and physicians delivered record levels of patient care to meet the demand caused by the Delta variant,” said Sam Hazen, Chief Executive Officer of HCA Healthcare. “Once again, the disciplined operating culture and strong execution by our teams were on display. I want to thank them for their tremendous work and dedication to serving others.”

Revenues in the third quarter of 2021 increased to $15.276 billion, compared to $13.311 billion in the third quarter of 2020. Net income attributable to HCA Healthcare, Inc. totaled $2.269 billion, or $7.00 per diluted share, compared to $668 million, or $1.95 per diluted share, in the third quarter of 2020. Results for the third quarter of 2021 include gains on sales of facilities of $1.047 billion, or $2.43 per diluted share, related to the sale of four hospitals in Georgia and other health care entity investments. Results for the third quarter of 2020 included a reversal of $822 million, or $1.72 per diluted share, in government stimulus income recorded in the second quarter of 2020 related to general distribution funds received from the Provider Relief Fund established by the Coronavirus Aid, Relief, and Economic Security (“CARES”) Act and $14 million, or $0.03 per diluted share, of gains on sales of facilities.

For the third quarter of 2021, Adjusted EBITDA totaled $3.224 billion, compared to $2.053 billion in the third quarter of 2020. Adjusted EBITDA is a non-GAAP financial measure. A table providing supplemental information on Adjusted EBITDA and reconciling net income attributable to HCA Healthcare, Inc. to Adjusted EBITDA is included in this release.

Same facility admissions and equivalent admissions increased 6.8 percent and 9.3 percent, respectively, in the third quarter of 2021, compared to the prior year period. Same facility emergency room visits increased 31.2 percent in the third quarter of 2021, compared to the prior year period. Same facility inpatient surgeries declined 4.9 percent, and same facility outpatient surgeries increased 6.4 percent in the third quarter of 2021, compared to the same period of 2020. Same facility revenue per equivalent admission increased 5.2 percent in the third quarter of 2021, compared to the third quarter of 2020, due to increases in acuity of patients treated and favorable payer mix in the quarter.

Because of the pandemic-related impact on volumes in the third quarter of 2020, the Company believes a comparison of volume statistics to the comparable period in 2019 provides additional context to the improvement in operations during 2021. The following table provides a summary of statistical measures for the third quarter of 2021 compared to the same period in 2019 on a same facility basis.

 
Third Quarter
  2021 2019 % Change
 
 
Same Facility:
Admissions 531,032   517,151   2.7 %
Equivalent Admissions 892,665   897,774   -0.6 %
         
Patient Days 2,836,248   2,482,756   14.2 %
Equivalent Patient Days 4,767,733   4,310,064   10.6 %
         
Inpatient Surgery Cases 125,533   141,313   -11.2 %
Outpatient Surgery Cases 242,450   241,019   0.6 %
         
Emergency Room Visits 2,301,968   2,198,357   4.7 %
 
 

Nine Months Ended September 30, 2021

Revenues for the nine months ended September 30, 2021 totaled $43.688 billion, compared to $37.240 billion in the same period of 2020. Net income attributable to HCA Healthcare, Inc. was $5.142 billion, or $15.43 per diluted share, compared to $2.328 billion, or $6.79 per diluted share, for the first nine months of 2020. Results through September 2021 include gains on sales of facilities of $1.057 billion, or $2.39 per diluted share, and losses on retirement of debt of $12 million, or $0.03 per diluted share. Results for the nine months ended September 30, 2020 included losses on sales of facilities of $6 million, or $0.03 per diluted share, and losses on retirement of debt of $295 million, or $0.66 per diluted share.

Balance Sheet and Cash Flows from Operations

As of September 30, 2021, HCA Healthcare, Inc.’s balance sheet reflected cash and cash equivalents of $1.027 billion, total debt of $32.299 billion, and total assets of $49.562 billion. During the third quarter of 2021, capital expenditures totaled $889 million, excluding acquisitions. Cash flows provided by operating activities in the third quarter totaled $2.277 billion, compared to $2.717 billion in the third quarter of 2020.

During the third quarter of 2021, the Company repurchased 9.605 million shares of its common stock at a cost of $2.329 billion. The Company had $2.658 billion remaining under its repurchase authorization as of September 30, 2021. As of September 30, 2021, the Company had $5.920 billion of availability under its credit facilities.

Dividend

HCA today announced that its Board of Directors declared a quarterly cash dividend of $0.48 per share on the Company’s common stock. The dividend will be paid on December 29, 2021 to stockholders of record at the close of business on December 14, 2021.

The declaration and payment of any future dividend will be subject to the discretion of the Board of Directors and will depend on a variety of factors, including the Company’s financial condition and results of operations and contractual restrictions. Future dividends are expected to be funded by cash balances and future cash flows from operations.

2021 Revised Guidance

The 2021 guidance ranges for the year have been revised from our second quarter release and are as follows:

  2021 Guidance Range
Revenues $58.7 to $59.3 billion
Adjusted EBITDA $12.50 to $12.80 billion
EPS (diluted) $17.20 to $17.80 per diluted share
Capital Expenditures Approximately $3.7 billion

The Company’s 2021 guidance contains a number of assumptions, including, among others, the Company’s current expectations regarding the impact of the COVID-19 pandemic and related government legislation, and excludes the impact of items such as, but not limited to, gains or losses on sales of facilities, losses on retirement of debt, legal claims costs and impairment of long-lived assets.

Adjusted EBITDA is a non-GAAP financial measure. A table reconciling forecasted net income attributable to HCA Healthcare, Inc. to forecasted Adjusted EBITDA is included in this release.

The Company’s guidance is based on current plans and expectations and is subject to a number of known and unknown uncertainties and risks, including those set forth below in the Company’s “Forward-Looking Statements.”

Earnings Conference Call

HCA Healthcare will host a conference call for investors at 9:00 a.m. Central Daylight Time today. All interested investors are invited to access a live audio broadcast of the call via webcast. The broadcast also will be available on a replay basis beginning this afternoon. The webcast can be accessed at: https://investor.hcahealthcare.com/events-and-presentations .

About the Company

As of September 30, 2021, HCA Healthcare operated 183 hospitals and approximately 2,000 sites of care, including surgery centers, freestanding emergency rooms, urgent care centers and physician clinics, in 20 states and the United Kingdom.

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the federal securities laws, which involve risks and uncertainties. Forward-looking statements include the Company’s financial guidance for the year ending December 31, 2021, as well as other statements that do not relate solely to historical or current facts. Forward-looking statements can be identified by the use of words like “may,” “believe,” “will,” “expect,” “project,” “estimate,” “anticipate,” “plan,” “initiative” or “continue.” These forward-looking statements are based on our current plans and expectations and are subject to a number of known and unknown uncertainties and risks, many of which are beyond our control, which could significantly affect current plans and expectations and our future financial position and results of operations. These factors include, but are not limited to, (1) developments related to COVID-19, including, without limitation, the length and severity of the pandemic and the spread of virus strains with new epidemiological characteristics; the volume of canceled or rescheduled procedures and the volume of COVID-19 patients cared for across our health systems; measures we are taking to respond to the COVID-19 pandemic; the impact and terms of government and administrative regulation and stimulus (including the Families First Coronavirus Response Act, the CARES Act, the Paycheck Protection Program and Health Care Enhancement Act, the Consolidated Appropriations Act, 2021, the American Rescue Plan Act of 2021 and other enacted and potential future legislation); changes in revenues due to declining patient volumes, changes in payer mix and deteriorating macroeconomic conditions (including increases in uninsured and underinsured patients); potential increased expenses related to labor, supply chain or other expenditures; workforce disruptions; supply shortages and disruptions; and the timing, availability and adoption of effective medical treatments and vaccines, (2) the impact of our substantial indebtedness and the ability to refinance such indebtedness on acceptable terms, as well as risks associated with disruptions in the financial markets and the business of financial institutions as the result of the COVID-19 pandemic which could impact us from a financial perspective, (3) the impact of the Patient Protection and Affordable Care Act, as amended by the Health Care and Education Reconciliation Act of 2010 (collectively, the “Affordable Care Act”), including the effects of changes or court challenges to the Affordable Care Act or additional changes to its implementation, the possible enactment of additional federal or state health care reforms and possible changes to other federal, state or local laws or regulations affecting the health care industry, including proposals to expand coverage of federally-funded insurance programs as an alternative to private insurance or establish a single-payer system (such reforms often referred to as “Medicare for All”), and also including any such laws or governmental regulations which are adopted in response to the COVID-19 pandemic, (4) the effects related to the implementation of sequestration spending reductions required under the Budget Control Act of 2011, related legislation extending these reductions, and those required under the Pay-As-You-Go Act of 2010 (“PAYGO Act”) as a result of the federal budget deficit impact of the American Rescue Plan Act of 2021, and the potential for future deficit reduction legislation that may alter these spending reductions, which include cuts to Medicare payments, or create additional spending reductions, (5) increases in the amount and risk of collectability of uninsured accounts and deductibles and copayment amounts for insured accounts, (6) the ability to achieve operating and financial targets, and attain expected levels of patient volumes and control the costs of providing services, (7) possible changes in Medicare, Medicaid and other state programs, including Medicaid supplemental payment programs or Medicaid waiver programs, that may impact reimbursements to health care providers and insurers and the size of the uninsured or underinsured population, (8) the highly competitive nature of the health care business, (9) changes in service mix, revenue mix and surgical volumes, including potential declines in the population covered under third-party payer agreements, the ability to enter into and renew third-party payer provider agreements on acceptable terms and the impact of consumer-driven health plans and physician utilization trends and practices, (10) the efforts of health insurers, health care providers, large employer groups and others to contain health care costs, (11) the outcome of our continuing efforts to monitor, maintain and comply with appropriate laws, regulations, policies and procedures, (12) increases in wages and the ability to attract and retain qualified management and personnel, including affiliated physicians, nurses and medical and technical support personnel, (13) the availability and terms of capital to fund the expansion of our business and improvements to our existing facilities, (14) changes in accounting practices, (15) changes in general economic conditions nationally and regionally in our markets, including economic and business conditions (and the impact thereof on the economy, financial markets and banking industry) resulting from the COVID-19 pandemic, (16) the emergence of and effects related to other pandemics, epidemics and infectious diseases, (17) future divestitures which may result in charges and possible impairments of long-lived assets, (18) changes in business strategy or development plans, (19) delays in receiving payments for services provided, (20) the outcome of pending and any future tax audits, disputes and litigation associated with our tax positions, (21) potential adverse impact of known and unknown government investigations, litigation and other claims that may be made against us, (22) the impact of potential cybersecurity incidents or security breaches, (23) our ongoing ability to demonstrate meaningful use of certified electronic health record (“EHR”) technology and the impact of interoperability requirements, (24) the impact of natural disasters, such as hurricanes and floods, or similar events beyond our control, (25) changes in the U.S. federal, state, or foreign tax laws including interpretive guidance that may be issued by taxing authorities or other standard setting bodies, and (26) other risk factors described in our annual report on Form 10-K for the year ended December 31, 2020 and our other filings with the Securities and Exchange Commission. Many of the factors that will determine our future results are beyond our ability to control or predict. In light of the significant uncertainties inherent in the forward-looking statements contained herein, readers should not place undue reliance on forward-looking statements, which reflect management’s views only as of the date hereof. We undertake no obligation to revise or update any forward-looking statements, or to make any other forward-looking statements, whether as a result of new information, future events or otherwise.

All references to “Company” and “HCA Healthcare” as used throughout this release refer to HCA Healthcare, Inc. and its affiliates.

HCA Healthcare, Inc.
Condensed Consolidated Comprehensive Income Statements
Third Quarter
(Dollars in millions, except per share amounts)
 
 
 
2021   2020
Amount   Ratio   Amount   Ratio
 
Revenues $ 15,276   100.0   % $ 13,311   100.0   %
 
Salaries and benefits   7,094   46.4     6,097   45.8  
Supplies   2,463   16.1     2,128   16.0  
Other operating expenses   2,530   16.6     2,251   16.9  
Government stimulus income reversal   -   -     822   6.2  
Equity in earnings of affiliates   (35 ) (0.2 )   (40 ) (0.3 )
Depreciation and amortization   716   4.7     694   5.2  
Interest expense   398   2.6     385   2.9  
Gains on sales of facilities   (1,047 ) (6.9 )   (14 ) (0.1 )
 
  12,119   79.3     12,323   92.6  
 
Income before income taxes   3,157   20.7     988   7.4  
 
Provision for income taxes   685   4.5     209   1.5  
 
Net income   2,472   16.2     779   5.9  
 
Net income attributable to noncontrolling interests   203   1.3     111   0.9  
 
Net income attributable to HCA Healthcare, Inc. $ 2,269   14.9   $ 668   5.0  
 
Diluted earnings per share $ 7.00   $ 1.95  
 
Shares used in computing diluted earnings per share (millions)   324.029     343.346  
 
Comprehensive income attributable to HCA Healthcare, Inc. $ 2,252   $ 715  
 
 
HCA Healthcare, Inc.
Condensed Consolidated Comprehensive Income Statements
For the Nine Months Ended September 30, 2021 and 2020
(Dollars in millions, except per share amounts)
 
 
 
2021   2020
Amount   Ratio   Amount   Ratio
 
Revenues $ 43,688   100.0   % $ 37,240   100.0   %
 
Salaries and benefits   19,780   45.3     17,545   47.1  
Supplies   7,067   16.2     5,999   16.1  
Other operating expenses   7,424   17.0     6,825   18.3  
Equity in earnings of affiliates   (78 ) (0.2 )   (48 ) (0.1 )
Depreciation and amortization   2,125   4.8     2,059   5.6  
Interest expense   1,168   2.7     1,201   3.2  
Losses (gains) on sales of facilities   (1,057 ) (2.4 )   6   -  
Losses on retirement of debt   12   -     295   0.8  
 
  36,441   83.4     33,882   91.0  
 
Income before income taxes   7,247   16.6     3,358   9.0  
 
Provision for income taxes   1,531   3.5     665   1.8  
 
Net income   5,716   13.1     2,693   7.2  
 
Net income attributable to noncontrolling interests   574   1.3     365   0.9  
 
Net income attributable to HCA Healthcare, Inc $ 5,142   11.8   $ 2,328   6.3  
 
Diluted earnings per share $ 15.43   $ 6.79  
 
Shares used in computing diluted earnings per share (millions)   333.248     343.014  
 
Comprehensive income attributable to HCA Healthcare, Inc. $ 5,152   $ 2,273  
HCA Healthcare, Inc.
Condensed Consolidated Balance Sheets
(Dollars in millions)
 
 
 
September 30,   June 30,   December 31,
2021   2021   2020
 
ASSETS
Current assets:
Cash and cash equivalents $ 1,027   $ 1,120   $ 1,793  
Accounts receivable   8,433     7,636     7,051  
Inventories   2,019     2,027     2,025  
Other   1,769     1,692     1,464  
  13,248     12,475     12,333  
 
Property and equipment, at cost   50,695     50,698     49,317  
Accumulated depreciation   (27,148 )   (27,227 )   (26,118 )
  23,547     23,471     23,199  
 
Investments of insurance subsidiaries   418     410     388  
Investments in and advances to affiliates   412     382     422  
Goodwill and other intangible assets   9,153     8,680     8,578  
Right-of-use operating lease assets   2,099     2,118     2,024  
Other   685     628     546  
 
$ 49,562   $ 48,164   $ 47,490  
 
 
 
LIABILITIES AND STOCKHOLDERS' EQUITY
Current liabilities:
Accounts payable $ 3,759   $ 3,531   $ 3,535  
Accrued salaries   2,134     1,896     1,720  
Other accrued expenses   3,481     2,935     3,240  
Long-term debt due within one year   250     253     209  
  9,624     8,615     8,704  
 
Long-term debt, less debt issuance costs and discounts of $253, $255 and $236   32,049     32,319     30,795  
Professional liability risks   1,522     1,585     1,486  
Right-of-use operating lease obligations   1,742     1,767     1,673  
Income taxes and other liabilities   2,800     2,088     1,940  
 
Stockholders' equity:
Stockholders' (deficit) equity attributable to HCA Healthcare, Inc.   (695 )   (593 )   572  
Noncontrolling interests   2,520     2,383     2,320  
  1,825     1,790     2,892  
$ 49,562   $ 48,164   $ 47,490  
 
HCA Healthcare, Inc.
Condensed Consolidated Statements of Cash Flows
For the Nine Months Ended September 30, 2021 and 2020
(Dollars in millions)
 
 
 
2021 2020
 
Cash flows from operating activities:
Net income $ 5,716   $ 2,693  
Adjustments to reconcile net income to net cash provided by operating activities:
Increase (decrease) in cash from operating assets and liabilities:
Accounts receivable   (1,312 )   930  
Inventories and other assets   (333 )   (36 )
Accounts payable and accrued expenses   731     542  
Government stimulus refund liability   -     6,123  
Depreciation and amortization   2,125     2,059  
Income taxes   185     (114 )
Losses (gains) on sales of facilities .   (1,057 )   6  
Losses on retirement of debt   12     295  
Amortization of debt issuance costs and discounts   21     22  
Share-based compensation   341     229  
Other   87     66  
 
Net cash provided by operating activities   6,516     12,815  
 
 
Cash flows from investing activities:
Purchase of property and equipment   (2,385 )   (2,087 )
Acquisition of hospitals and health care entities   (488 )   (380 )
Sales of hospitals and health care entities   1,980     68  
Change in investments   (38 )   (40 )
Other   2     (44 )
 
Net cash used in investing activities   (929 )   (2,483 )
 
 
Cash flows from financing activities:
Issuances of long-term debt   4,337     2,700  
Net change in revolving credit facilities   500     (2,480 )
Repayment of long-term debt   (3,787 )   (3,403 )
Distributions to noncontrolling interests   (501 )   (393 )
Payment of debt issuance costs   (38 )   (35 )
Payment of dividends   (476 )   (153 )
Repurchase of common stock   (6,143 )   (441 )
Other   (241 )   (156 )
 
Net cash used in financing activities   (6,349 )   (4,361 )
 
Effect of exchange rate changes on cash and cash equivalents   (4 )   (4 )
 
Change in cash and cash equivalents   (766 )   5,967  
Cash and cash equivalents at beginning of period   1,793     621  
 
 
Cash and cash equivalents at end of period $ 1,027   $ 6,588  
 
 
Interest payments $ 1,127   $ 1,230  
Income tax payments, net $ 1,346   $ 779  
 
HCA Healthcare, Inc.
Operating Statistics
 
      For the Nine Months
Third Quarter     Ended September 30,
                             
2021   2020   2021   2020
Operations:
Number of Hospitals   183     187     183     187  
Number of Freestanding Outpatient Surgery Centers*   123     121     123     121  
Licensed Beds at End of Period   48,950     49,473     48,950     49,473  
Weighted Average Beds in Service   42,088     42,426     42,304     42,304  
Reported:
 
Admissions   536,848     506,756     1,575,269     1,487,992  
% Change   5.9 %   5.9 %
Equivalent Admissions   905,627     835,576     2,654,328     2,447,747  
% Change   8.4 %   8.4 %
Revenue per Equivalent Admission $ 16,868   $ 15,930   $ 16,459   $ 15,214  
% Change   5.9 %   8.2 %
Inpatient Revenue per Admission $ 18,102   $ 16,265   $ 17,115   $ 15,531  
% Change   11.3 %   10.2 %
 
Patient Days   2,865,220     2,593,139     8,166,211     7,476,794  
% Change   10.5 %   9.2 %
Equivalent Patient Days   4,833,197     4,275,481     13,760,066     12,299,326  
% Change   13.0 %   11.9 %
 
Inpatient Surgery Cases   126,436     133,492     390,486     387,228  
% Change   -5.3 %   0.8 %
Outpatient Surgery Cases   249,192     232,493     742,527     629,723  
% Change   7.2 %   17.9 %
 
Emergency Room Visits   2,338,180     1,813,661     6,308,386     5,594,484  
% Change   28.9 %   12.8 %
 
Outpatient Revenues as a Percentage of Patient Revenues   34.1 %   35.5 %   36.0 %   35.0 %
 
Average Length of Stay (days)   5.337     5.117     5.184     5.025  
 
Occupancy (weighted average beds in service)   74.0 %   66.4 %   70.7 %   64.5 %
 
Same Facility:
 
Admissions   531,032     497,309     1,549,732     1,458,609  
% Change   6.8 %   6.2 %
Equivalent Admissions   892,665     817,079     2,603,550     2,392,119  
% Change   9.3 %   8.8 %
Revenue per Equivalent Admission $ 16,799   $ 15,962   $ 16,456   $ 15,247  
% Change   5.2 %   7.9 %
Inpatient Revenue per Admission $ 18,055   $ 16,323   $ 17,148   $ 15,610  
% Change   10.6 %   9.9 %
 
Inpatient Surgery Cases   125,533     131,957     386,190     382,121  
% Change   -4.9 %   1.1 %
Outpatient Surgery Cases   242,450     227,918     724,914     616,082  
% Change   6.4 %   17.7 %
 
Emergency Room Visits   2,301,968     1,753,887     6,162,206     5,419,887  
% Change   31.2 %   13.7 %
* Excludes freestanding endoscopy centers (21 centers at both September 30, 2021 and September 30, 2020).
HCA Healthcare, Inc.
Supplemental Non-GAAP Disclosures
Operating Results Summary
(Dollars in millions, except per share amounts)
 
 
        For the Nine Months
Third Quarter   Ended September 30,
2021   2020   2021   2020
 
Revenues $ 15,276   $ 13,311   $ 43,688   $ 37,240  
 
Net income attributable to HCA Healthcare, Inc. $ 2,269   $ 668   $ 5,142   $ 2,328  
Losses (gains) on sales of facilities (net of tax)   (788 )   (10 )   (795 )   9  
Losses on retirement of debt (net of tax)   -     -     9     227  
 
Net income attributable to HCA Healthcare, Inc., excluding losses (gains) on sales of facilities and losses on retirement of debt (a)   1,481     658     4,356     2,564  
Depreciation and amortization   716     694     2,125     2,059  
Interest expense   398     385     1,168     1,201  
Provision for income taxes   426     205     1,272     730  
Net income attributable to noncontrolling interests   203     111     574     365  
 
Adjusted EBITDA (a) $ 3,224   $ 2,053   $ 9,495   $ 6,919  
 
Adjusted EBITDA margin (a)   21.1 %   15.4 %   21.7 %   18.6 %
 
Diluted earnings per share:
Net income attributable to HCA Healthcare, Inc. $ 7.00   $ 1.95   $ 15.43   $ 6.79  
Losses (gains) on sales of facilities   (2.43 )   (0.03 )   (2.39 )   0.03  
Losses on retirement of debt   -     -     0.03     0.66  
Net income attributable to HCA Healthcare, Inc., excluding losses (gains) on sales of facilities and losses on retirement of debt (a) $ 4.57   $ 1.92   $ 13.07   $ 7.48  
 
Shares used in computing diluted earnings per share (millions)   324.029     343.346     333.248     343.014  
 
(a) Net income attributable to HCA Healthcare, Inc., excluding losses (gains) on sales of facilities and losses on retirement of debt, and Adjusted EBITDA should not be considered as measures of financial performance under generally accepted accounting principles ("GAAP"). We believe net income attributable to HCA Healthcare, Inc., excluding losses (gains) on sales of facilities and losses on retirement of debt, and Adjusted EBITDA are important measures that supplement discussions and analysis of our results of operations. We believe it is useful to investors to provide disclosures of our results of operations on the same basis used by management. Management relies upon net income attributable to HCA Healthcare, Inc., excluding losses (gains) on sales of facilities and losses on retirement of debt, and Adjusted EBITDA as the primary measures to review and assess operating performance of its health care facilities and their management teams.
 
Management and investors review both the overall performance (including net income attributable to HCA Healthcare, Inc., excluding losses (gains) on sales of facilities and losses on retirement of debt, and GAAP net income attributable to HCA Healthcare, Inc.) and operating performance (Adjusted EBITDA) of our health care facilities. Adjusted EBITDA and the Adjusted EBITDA margin (Adjusted EBITDA divided by revenues) are utilized by management and investors to compare our current operating results with the corresponding periods during the previous year and to compare our operating results with other companies in the health care industry. It is reasonable to expect that losses (gains) on sales of facilities and losses on retirement of debt will occur in future periods, but the amounts recognized can vary significantly from period to period, do not directly relate to the ongoing operations of our health care facilities and complicate period comparisons of our results of operations and operations comparisons with other health care companies.
 
Net income attributable to HCA Healthcare, Inc., excluding losses (gains) on sales of facilities and losses on retirement of debt, and Adjusted EBITDA are not measures of financial performance under GAAP, and should not be considered as alternatives to net income attributable to HCA Healthcare, Inc. as a measure of operating performance or cash flows from operating, investing and financing activities as a measure of liquidity. Because net income attributable to HCA Healthcare, Inc., excluding losses (gains) on sales of facilities and losses on retirement of debt, and Adjusted EBITDA are not measurements determined in accordance with GAAP and are susceptible to varying calculations, net income attributable to HCA Healthcare, Inc., excluding losses (gains) on sales of facilities and losses on retirement of debt, and Adjusted EBITDA, as presented, may not be comparable to other similarly titled measures presented by other companies.
HCA Healthcare, Inc.
Supplemental Non-GAAP Disclosures
2021 Operating Results Forecast
(Dollars in millions, except per share amounts)
 
 
For the Year Ending
December 31, 2021
Low   High
 
Revenues $ 58,700 $ 59,300
 
Net income attributable to HCA Healthcare, Inc. (a) $ 5,650 $ 5,830
Depreciation and amortization   2,840   2,860
Interest expense   1,560   1,580
Provision for income taxes   1,700   1,750
Net income attributable to noncontrolling interests   750   780
 
Adjusted EBITDA (a) (b) $ 12,500 $ 12,800
 
Diluted earnings per share:
Net income attributable to HCA Healthcare, Inc. $ 17.20 $ 17.80
 
Shares used in computing diluted earnings per share (millions)   329.000   329.000
 
The Company's forecasted guidance range is based on current plans and expectations and is subject to a number of known and unknown uncertainties and risks.
 
 
(a) The Company does not forecast the impact of items such as, but not limited to, losses (gains) on sales of facilities, losses on retirement of debt, legal claim costs (benefits) and impairments of long-lived assets because the Company does not believe that it can forecast these items with sufficient accuracy.
 
(b) Adjusted EBITDA should not be considered a measure of financial performance under generally accepted accounting principles ("GAAP"). We believe Adjusted EBITDA is an important measure that supplements discussions and analysis of our results of operations. We believe it is useful to investors to provide disclosures of our results of operations on the same basis used by management. Management relies upon Adjusted EBITDA as a primary measure to review and assess operating performance of its health care facilities and their management teams.
 
Management and investors review both the overall performance (including net income attributable to HCA Healthcare, Inc.) and operating performance (Adjusted EBITDA) of our health care facilities. Adjusted EBITDA and the Adjusted EBITDA margin (Adjusted EBITDA divided by revenues) are utilized by management and investors to compare our current operating results with the corresponding periods during the previous year and to compare our operating results with other companies in the health care industry.
 
Adjusted EBITDA is not a measure of financial performance under GAAP and should not be considered as an alternative to net income attributable to HCA Healthcare, Inc. as a measure of operating performance or cash flows from operating, investing and financing activities as a measure of liquidity. Because Adjusted EBITDA is not a measurement determined in accordance with GAAP and is susceptible to varying calculations, Adjusted EBITDA, as presented, may not be comparable to other similarly titled measures presented by other companies.

 

View source version on businesswire.com: https://www.businesswire.com/news/home/20211022005081/en/

SOURCE: HCA Healthcare

INVESTOR CONTACT:
Mark Kimbrough
615-344-2688 MEDIA CONTACT:
Harlow Sumerford
615-344-1851

COMTEX_395661848/2456/2021-10-22T07:00:06

Is there a problem with this press release? Contact the source provider Comtex at editorial@comtex.com. You can also contact MarketWatch Customer Service via our Customer Center.

Copyright Business Wire 2021

/zigman2/quotes/205934574/composite
US : U.S.: NYSE
$ 257.00
+2.59 +1.02%
Volume: 1.21M
Jan. 14, 2022 4:00p
P/E Ratio
13.09
Dividend Yield
0.75%
Market Cap
$79.93 billion
Rev. per Employee
$210,840
loading...

Comtex

Partner Center

Link to MarketWatch's Slice.